泰山医学院学报
泰山醫學院學報
태산의학원학보
Journal of Taishan Medical College
2015年
11期
1228-1229
,共2页
李明生%王婷婷%李胜德%杨圣强%谭泽龙
李明生%王婷婷%李勝德%楊聖彊%譚澤龍
리명생%왕정정%리성덕%양골강%담택룡
盐酸氢吗啡酮%患者自控静脉镇痛%剂量
鹽痠氫嗎啡酮%患者自控靜脈鎮痛%劑量
염산경마배동%환자자공정맥진통%제량
hydromorphone hydrochloride%PCIA%dose
目的:通过比较不同剂量的盐酸氢吗啡酮用于患者术后镇痛效果的研究,探究盐酸氢吗啡酮在术后镇痛中的最有效剂量。方法选择40例择期食管癌患者随机分为 A 组(n =10):盐酸氢吗啡酮4 mg,昂丹司琼8 mg,氟比洛芬酯200 mg,生理盐水加至100 ml;B 组(n =10):盐酸氢吗啡酮6 mg,昂丹司琼8 mg,氟比洛芬酯200mg,生理盐水加至100 ml;C 组(n =10):盐酸氢吗啡酮8 mg,昂丹司琼8 mg,氟比洛芬酯200 mg,生理盐水加至100 ml;D 组(n =10):盐酸氢吗啡酮10 mg,昂丹司琼8 mg,氟比洛芬酯200mg,生理盐水加至100 ml。各组均选用电子输注泵,流速设置2 ml/ h,一次 PCIA 剂量2 ml,锁定时间15 min,持续镇痛48 h。结果盐酸氢吗啡酮 A、B 组与盐酸氢吗啡酮 C、D 组相比,镇痛评分(VAS)、镇静评分有统计学差异(P≤0.05)。C 组与 D 组相比,镇痛评分(VAS)、镇静评分、按压次数均无明显的统计学差异,但 C 组病人费用少于 D 组。结论盐酸氢吗啡酮 C 组用于食管癌根治术后静脉镇痛,效果确切,不良反应少。
目的:通過比較不同劑量的鹽痠氫嗎啡酮用于患者術後鎮痛效果的研究,探究鹽痠氫嗎啡酮在術後鎮痛中的最有效劑量。方法選擇40例擇期食管癌患者隨機分為 A 組(n =10):鹽痠氫嗎啡酮4 mg,昂丹司瓊8 mg,氟比洛芬酯200 mg,生理鹽水加至100 ml;B 組(n =10):鹽痠氫嗎啡酮6 mg,昂丹司瓊8 mg,氟比洛芬酯200mg,生理鹽水加至100 ml;C 組(n =10):鹽痠氫嗎啡酮8 mg,昂丹司瓊8 mg,氟比洛芬酯200 mg,生理鹽水加至100 ml;D 組(n =10):鹽痠氫嗎啡酮10 mg,昂丹司瓊8 mg,氟比洛芬酯200mg,生理鹽水加至100 ml。各組均選用電子輸註泵,流速設置2 ml/ h,一次 PCIA 劑量2 ml,鎖定時間15 min,持續鎮痛48 h。結果鹽痠氫嗎啡酮 A、B 組與鹽痠氫嗎啡酮 C、D 組相比,鎮痛評分(VAS)、鎮靜評分有統計學差異(P≤0.05)。C 組與 D 組相比,鎮痛評分(VAS)、鎮靜評分、按壓次數均無明顯的統計學差異,但 C 組病人費用少于 D 組。結論鹽痠氫嗎啡酮 C 組用于食管癌根治術後靜脈鎮痛,效果確切,不良反應少。
목적:통과비교불동제량적염산경마배동용우환자술후진통효과적연구,탐구염산경마배동재술후진통중적최유효제량。방법선택40례택기식관암환자수궤분위 A 조(n =10):염산경마배동4 mg,앙단사경8 mg,불비락분지200 mg,생리염수가지100 ml;B 조(n =10):염산경마배동6 mg,앙단사경8 mg,불비락분지200mg,생리염수가지100 ml;C 조(n =10):염산경마배동8 mg,앙단사경8 mg,불비락분지200 mg,생리염수가지100 ml;D 조(n =10):염산경마배동10 mg,앙단사경8 mg,불비락분지200mg,생리염수가지100 ml。각조균선용전자수주빙,류속설치2 ml/ h,일차 PCIA 제량2 ml,쇄정시간15 min,지속진통48 h。결과염산경마배동 A、B 조여염산경마배동 C、D 조상비,진통평분(VAS)、진정평분유통계학차이(P≤0.05)。C 조여 D 조상비,진통평분(VAS)、진정평분、안압차수균무명현적통계학차이,단 C 조병인비용소우 D 조。결론염산경마배동 C 조용우식관암근치술후정맥진통,효과학절,불량반응소。
Objective:To make clinical study of different doses of hydromorphone for patient-controlled intravenous an-algesia(PCIA),and explore hydromorphone postoperative intravenous analgesia methods and the optimal dose. Methods:Forty patients undergoing elective abdominal surgery were selected and divided into group A(n = 10):hydromorphone 4 mg,ondansetron 8 mg,Kay Fun 200mg,group B( n = 10):hydromorphone 6 mg,ondansetron 8 mg,Kay Fun 200mg, group C( n = 10):hydromorphone 4 mg,ondansetron 8 mg,Kay Fun 200mg,group D(n = 10):hydromorphone 10mg, ondansetron 8 mg,Kay Fun 200mg,and each therapy was diluted to 100ml with 0. 9% NS. Four groups were controlled by electronic infusion pumps,with injection infusion speed of 2 - 4ml/ h,PCA dose of 2 - 4ml,lockout time of 30min. The analgesia(VAS)and sedation(Ramsay)scores at 4,6,8,12,24,36,48h,the frequency of PCA compression,as well as the occurrence of nausea,vomitting and adverse reactions were recorded. Results:Compared with hydromorphone C,D group,hydromorphone AB group had higher VAS scores and(Ramsay)scores(P≤0. 05). Cmpared to Group D,VAS scores and(Ramsay)scores in Group C were not statisticslly significant(P > 0. 05)However,the cost of patients in group C was less than that in group D. Conclusion:The use of Hydromorphone C group in PCIA shows satisfactory analgesic effi-cacy and good safety in patients after undergoing abdominal operation.